HIND

Vyome Holdings, Inc. (Ticker: HIND) is an emerging clinical-stage biopharmaceutical company dedicated to the development of innovative therapeutic solutions targeting immuno-inflammatory and rare diseases. Located in Princeton, New Jersey, the company harnesses advanced research methodologies and state-of-the-art technologies to tackle significant unmet medical needs both in the United States and globally. With a robust pipeline of promising candidates, Vyome is strategically positioned to make a considerable impact in the healthcare sector, advancing the treatment of complex medical conditions.